期刊
JOURNAL OF FUNCTIONAL FOODS
卷 35, 期 -, 页码 641-647出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jff.2017.06.037
关键词
alpha-Amylase; AR42J cell; Diabetes treatment; Inhibitory activity; Pinto bean peptide
资金
- Universiti Sains Malaysia RUI Grant [1001/CAATS/814257]
The current work investigated the alpha-amylase inhibitory activity of five selected Pinto bean peptides (PBPs) using AR42J cell. The objectives were: (a) to prove the potential of PBPs as alpha-amylase inhibitor in living cells, and (b) to investigate the inhibition mode of PBPs. Results showed that PBP9 obtained the lowest IC50 value of 0.31 mM followed by PBP7 (5.92 mM), PBP1 (6.08 mM), PBP6 (6.14 mM) and PBP3 (6.64 mM). In the MTT assay, all PBP showed a dose-dependent trend, whereby lower concentration of PBP demonstrated a higher cell viability. By using PBP concentrations of 0.33-8.3 mM, Michaelis-Menten kinetic parameters and Lineweaver-Burk plots revealed that Km and Vmax values were ranged from 38.52-794.38 mM and 0.72-1.15 mM/min, respectively, resulting in uncompetitive (PBP3, PBP6 and PBP7) and unusual (PBP1 and PBP9) alpha-amylase inhibition modes. It was suggested that PBP could be considered as new agents for the diabetes treatment. (C) 2017 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据